Tonghua Golden-horse Pharmaceutical Industry Co Ltd
000766
Company Profile
Business description
Tonghua Golden-horse Pharmaceutical Industry Co Ltd is a pharmaceutical company engaged in the manufacturing and sale of pharmaceutical products. It is a comprehensive pharmaceutical company integrating the production, sales, and research and development of pharmaceuticals. Tonghua's products mainly focus on rheumatism, bone diseases, digestion, tumors, and gynecology and distributing it mainly in the eastern part of China.
Contact
No. 999, Jinma Road
Erdaojiang District
TonghuaJilin134001
CHNT: +86 4353246712
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2026
Employees
1,480
Stocks News & Analysis
stocks
Cheap ASX share may have more room to run
Shares are cheap despite rebounding share price, yet risks remain.
stocks
ASX listed media giant drives strong earnings growth
Digital growth drives earnings beat for media share.
stocks
ASX real estate platform outperforms yet questions remain
Valuation remains a key concern despite strong August reporting.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,429.60 | 7.80 | -0.08% |
| CAC 40 | 8,714.93 | 15.22 | 0.17% |
| DAX 40 | 26,319.45 | 179.32 | 0.69% |
| Dow JONES (US) | 54,036.93 | 151.83 | 0.28% |
| FTSE 100 | 10,901.09 | 33.20 | 0.31% |
| HKSE | 25,668.03 | 137.75 | 0.54% |
| NASDAQ | 26,690.62 | 342.26 | 1.30% |
| Nikkei 225 | 66,665.77 | 1,059.06 | 1.61% |
| NZX 50 Index | 13,893.06 | 68.93 | 0.50% |
| S&P 500 | 7,757.64 | 47.68 | 0.62% |
| S&P/ASX 200 | 9,237.10 | 12.50 | -0.14% |
| SSE Composite Index | 3,940.04 | 39.68 | 1.02% |